• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 4. Aggregation kinetics and gel formation in modestly concentrated suspensions of oppositely charged model ceramic colloids: a numerical study
  M. A. Piechowiak,A. Videcoq,R. Ferrando,D. Bochicchio,C. Pagnoux,F. Rossignol Phys. Chem. Chem. Phys., 2012,14, 1431-1439
• 5. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Recent Advances in the Application of 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde (CAS: 1198277-84-7) in Chemical Biology and Pharmaceutical Research

The compound 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde (CAS: 1198277-84-7) has emerged as a key intermediate in the synthesis of biologically active molecules, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its versatility as a building block for the construction of complex heterocyclic systems, which are often found in drug candidates targeting various diseases, including cancer and inflammatory disorders.

One of the most significant applications of this compound is in the synthesis of JAK (Janus kinase) inhibitors. JAK kinases play a critical role in cytokine signaling pathways, and their dysregulation is associated with numerous autoimmune and inflammatory diseases. Researchers have utilized 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde as a starting material to develop novel JAK inhibitors with improved selectivity and pharmacokinetic properties. Recent publications demonstrate its use in the synthesis of compounds that show promising activity in preclinical models of rheumatoid arthritis and psoriasis.

In addition to its role in JAK inhibitor development, this compound has been employed in the construction of PROTACs (Proteolysis Targeting Chimeras), a revolutionary approach in drug discovery. PROTACs are bifunctional molecules that recruit E3 ubiquitin ligases to target proteins for degradation. The aldehyde functionality of 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde allows for efficient conjugation with various warheads and E3 ligase ligands, enabling the rapid assembly of diverse PROTAC libraries for screening against challenging drug targets.

Recent synthetic methodologies have focused on optimizing the preparation of this compound to improve yield and purity. A 2023 study published in the Journal of Medicinal Chemistry described a novel, scalable route to 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde that reduces the number of synthetic steps while maintaining high overall yield. This advancement is particularly important for facilitating its use in large-scale drug discovery programs.

The compound's mechanism of action in various biological contexts continues to be an area of active investigation. Structural-activity relationship (SAR) studies utilizing derivatives of 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde have provided valuable insights into the molecular interactions between small molecules and their protein targets. These studies have led to the identification of critical pharmacophores that contribute to binding affinity and selectivity in several target classes.

Looking forward, the unique chemical properties of 4-bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde position it as a valuable tool in the development of next-generation therapeutics. Its versatility in medicinal chemistry applications, combined with recent synthetic improvements, suggests that this compound will continue to play a significant role in drug discovery efforts targeting challenging disease pathways. Ongoing research is exploring its potential in emerging areas such as targeted protein degradation and covalent inhibitor development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)